satraplatin News
Most Popular satraplatin Story
GPC shares crater on Phase III cancer failure
Germany's GPC Biotech saw its already battered stock price crater this morning after announcing that its experimental prostate cancer drug, satraplatin, failed to help patients live longer in a Read more...
Latest Headlines
- August 6, 2008
- May 7, 2008
- November 28, 2007
- November 15, 2007
- November 9, 2007
- October 31, 2007
- August 23, 2007
- August 8, 2007
- August 1, 2007
- July 30, 2007
- July 25, 2007
- July 23, 2007
- November 15, 2006
- September 24, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
